In fact, higher uPAR del 4/5 mRNA levels were associated with shorter disease-free survival in breast cancer patients [29] and with advanced tumour stage in soft-tissue sarcoma patients [30]; by contrast, mRNA expression level of uPAR del 4/5 was not clinically relevant in advanced ovarian cancer [31]. Here, PLAUR is linked to ovarian cancer.